Background: Significant controversy exists in the literature regarding the role of pregnancy in the prognosis of breast cancer. We designed a matched case-case study, matching pregnancy-associated breast cancer (PABC) cases with breast cancer cases for stage, age, and year of diagnosis. Patients and Methods:39 consecutive cases of PABC were matched with 39 premenopausal cases of breast cancer. Univariate and multivariate survival analyses followed by adjustment for stage, grade, estrogen receptor status, and age at diagnosis, were performed. Results: Regarding overall survival (OS), univariate analysis pointed to longer OS in non-PABC cases vs. PABC cases. Accordingly, a more advanced stage predicted shorter survival. In the multivariate analysis, the independent aggravating effect mediated by pregnancy persisted. Interestingly, a post hoc nested analysis within PABC cases indicated that the 3rd trimester pointed to shorter OS. The aforementioned results on OS were also replicated during the examination of relapse-free survival. Conclusion: Implementing a matched case-case design, the present study points to pregnancy as a poor prognostic factor for breast cancer.

1.
Viswanathan S, Ramaswamy B: Pregnancy-associated breast cancer. Clin Obstet Gynecol 2011;54:546-555.
2.
Asgeirsson KS: Pregnancy-associated breast cancer. Acta Obstet Gynecol Scand 2011;90:158-166.
3.
Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N; ESMO Guidelines Working Group: cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v266-273.
4.
Halaska MJ, Pentheroudakis G, Strnad P, Stankusova H, Chod J, Robova H, Petruzelka L, Rob L, Pavlidis N: Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J 2009;15:461-467.
5.
Heck KE, Schoendorf KC, Ventura SJ, Kiely JL: Delayed childbearing by education level in the United States, 1969-1994. Matern Child Health J 1997;1:81-88.
6.
Litton JK, Theriault RL: Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 2010;15:1238-1247.
7.
Ezzat A, Raja MA, Berry J, Zwaan FE, Jamshed A, Rhydderch D, Rostom A, Bazarbashi S: Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 1999;8:367-370.
8.
Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH: The impact of pregnancy on breast cancer outcomes in women < or = 35 years. Cancer 2009;115:1174-1184.
9.
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G: Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992;166:781-787.
10.
Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR: Childbearing and survival after breast carcinoma in young women. Cancer 2003;98:1131-1140.
11.
Ives A, Saunders C, Bulsara M, Semmens J: Pregnancy after breast cancer: population based study. BMJ 2007;334:194.
12.
Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B; Danish Breast Cancer Cooperative Group: Pregnancy after treatment of breast cancer - a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 2008;47:545-549.
13.
De Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD: Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 2010;101:534-542.
14.
Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, Simozuma K, Enomoto K, Fujiwara K, Nanasawa T, et al.: Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 1992;83:1143-1149.
15.
Zhang J, Liu G, Wu J, Lu JS, Shen KW, Han QX, Shen ZZ, Shao ZM: Pregnancy-associated breast cancer: a case control and long-term follow-up study in China. J Exp Clin Cancer Res 2003;22:23-27.
16.
Murphy C, Mallam D, Stein S, Patil S, Howard J, Sklarin NT, Gemignani M, Hudis C, Seidman AD: Pathologic features and outcomes of pregnancy-associated breast cancer (PABC): a case control study. J Clin Oncol 2010;28:1589.
17.
Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 1996;67:751-755.
18.
Azim HA Jr, Botteri E, Renne G, Dell'orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart M, Goldhirsch A, Viale G, Peccatori FA: The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol 2012;51:653-661.
19.
Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith: Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008;112:71-78.
20.
Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, Lejeune C, Martin PM, Piana L: Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 1997;72:720-727.
21.
Moreira WB, Brandão EC, Soares AN, Lucena CE, Antunes CM: Prognosis for patients diagnosed with pregnancy-associated breast cancer: a paired case-control study. Sao Paulo Med J 2010;128:119-124.
22.
Aebi S, Davidson T, Gruber G, Cardoso F; ESMO Guidelines Working Group: Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22:vi12-24.
23.
Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH: Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 2000;17:293-300.
24.
Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M: Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 2011;20:1865-1872.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.